Speaker illustration

Doctor Kieran Docherty

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
European Society of Cardiology
Heart Failure Association

Relationship between endothelin-1, heart failure with reduced ejection fraction and dapagliflozin: findings from DAPA-HF

Event: ESC Congress 2022

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: SGLT2 inhibitors: pearls from recent trials and surveys

Thumbnail

The effect of dapagliflozin according to iron status and its effect on iron metabolism: insights from DAPA-HF

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Young Investigator Award: clinical research

Thumbnail

Fast conducting atrial fibrillation and newly diagnosed heart failure.

Event: Heart Failure 2022

Topic: Atrial Fibrillation (AF)

Session: Atrial fibrillation

Thumbnail

The effect of dapagliflozin across the spectrum of baseline risk: a post-hoc analysis of DAPA-HF

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic Heart Failure ePosters

Thumbnail

Declining risk of heart failure hospitalisation following first acute myocardial infarction in Scotland between 1990-2015

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Real world heart failures populations

Thumbnail

ESC 365 is supported by

logo Novo Nordisk